Team:TU-Eindhoven/Project

From 2013.igem.org

(Difference between revisions)
(→Abstract)
 
(78 intermediate revisions not shown)
Line 2: Line 2:
{{:Team:TU-Eindhoven/Template:MenuBar}}
{{:Team:TU-Eindhoven/Template:MenuBar}}
 +
{{:Team:TU-Eindhoven/Template:Abstract}}
==Abstract==
==Abstract==
-
Magnetic resonance imaging (MRI) provides the clinical and research field with high quality images of a patient’s body. Therefore, MRI has become an irreplaceable tool for detecting cancers. Nevertheless, it has the disadvantage of using heavy metals in {{:Team:TU-Eindhoven/Template:Tooltip | text=contrast agents | tooltip=Substance that can be distinguished from its surroundings on a MRI scan }}. Yet without heavy metals MRI would not be able to detect cancer or any other disease efficiently, or would it?
+
Our project presents an alternative solution to the use of heavy metals MRI {{:Team:TU-Eindhoven/Template:Tooltip | text=contrast agents | tooltip=Substance that can be distinguished from its surroundings on an MRI scan }} (since the most commonly used heavy metal Gadolinium may be involved in the induction of diseases{{:Team:TU-Eindhoven/Template:Ref | id=GNSF | author=T Grobner and FC Prischl | title=Gadolinium and nephrogenic systemic fibrosis| journal=Kidney International | edition=72 | pages=260–264 | year=2007 }}{{:Team:TU-Eindhoven/Template:Ref | id=Gsrf34 | author=Ihsan Ergün, Kenan Keven, et all. | title=The safety of gadolinium in patients with stage 3 and 4 renal failure | journal=Nephrology Dialysis Transplantation | edition=21 | pages=697-700 | year=2006 }} and may be toxic when the patient has kidney failures{{:Team:TU-Eindhoven/Template:Ref | id=Gint | author=I. Buhaescu and H. Izzedine | title=Gadolinium-induced nephrotoxicity | journal=The International Journal of Clinical Practice | edition=62 | pages=1113-1118 | year=2008 }}) by focusing on {{:Team:TU-Eindhoven/Template:Tooltip | text=CEST | tooltip=Chemical Exchange Saturation Transfer }} MRI. Within CEST  imaging, proteins enclosing hydrogen atoms can generate high quality images.  Escherichia coli are used to express CEST proteins when the  bacteria sense a hypoxic environment due to a promoter designed for this purpose, thus working as both a production and delivery system for the CEST MRI contrast agent.  A rapidly evolving research area in the field of oncology is the one focused on bacterial based cancer therapies, in which bacteria like E. Coli and Salmonella are used to induce cell death. Based on this type of cancer therapy, and considering that hypoxic regions are related to tumors, our eventual goal is to use this device to target and image tumors in humans by injecting the bacteria into the bloodstream. A secondary application is the tracking bacteria in bacterial infection studies. For the iGEM competition however, the proteins were only expressed ex-vivo: in  both aerobic and anaerobic conditions. An efficient assessment of the CEST properties of the proteins was performed and we confirmed the promoters ability to express proteins in anaerobic environments.
 +
{{:Team:TU-Eindhoven/Template:AbstractEnd}}
-
Our project focuses on {{:Team:TU-Eindhoven/Template:Tooltip | text=CEST | tooltip=Chemical Exchange Saturation Transfer }} MRI. Within CEST imaging, proteins enclosing hydrogen atoms can be used to generate images with the same quality as those produced with heavy metals. We use Escherichia coli K-12 to create CEST proteins when the bacteria sense a hypoxic environment, thus working as a production factory and delivery system. Based on the principle of our project, we propose two applications, tumor CEST MR Imaging and tracking of bacteria in bacterial infections studies.
+
==References==
 +
{{:Team:TU-Eindhoven/Template:RefList}}
{{:Team:TU-Eindhoven/Template:BaseFooter}}
{{:Team:TU-Eindhoven/Template:BaseFooter}}
 +
{{:Team:TU-Eindhoven/Template:Sponsors}}
 +
{{:Team:TU-Eindhoven/Template:UseReferencing}}
{{:Team:TU-Eindhoven/Template:SetTitle | menu=project | page=Project Summary}}
{{:Team:TU-Eindhoven/Template:SetTitle | menu=project | page=Project Summary}}
 +
{{:Team:TU-Eindhoven/Template:SetHeader | nr=3}}

Latest revision as of 22:55, 18 October 2013

Abstract

Our project presents an alternative solution to the use of heavy metals MRI contrast agents (since the most commonly used heavy metal Gadolinium may be involved in the induction of diseasesGNSFT Grobner and FC Prischl, Gadolinium and nephrogenic systemic fibrosis. Kidney International 72, 260–264 (2007)Gsrf34Ihsan Ergün, Kenan Keven, et all., The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrology Dialysis Transplantation 21, 697-700 (2006) and may be toxic when the patient has kidney failuresGintI. Buhaescu and H. Izzedine, Gadolinium-induced nephrotoxicity. The International Journal of Clinical Practice 62, 1113-1118 (2008)) by focusing on CEST MRI. Within CEST imaging, proteins enclosing hydrogen atoms can generate high quality images. Escherichia coli are used to express CEST proteins when the bacteria sense a hypoxic environment due to a promoter designed for this purpose, thus working as both a production and delivery system for the CEST MRI contrast agent. A rapidly evolving research area in the field of oncology is the one focused on bacterial based cancer therapies, in which bacteria like E. Coli and Salmonella are used to induce cell death. Based on this type of cancer therapy, and considering that hypoxic regions are related to tumors, our eventual goal is to use this device to target and image tumors in humans by injecting the bacteria into the bloodstream. A secondary application is the tracking bacteria in bacterial infection studies. For the iGEM competition however, the proteins were only expressed ex-vivo: in both aerobic and anaerobic conditions. An efficient assessment of the CEST properties of the proteins was performed and we confirmed the promoters ability to express proteins in anaerobic environments.

References

Go to Top   

Retrieved from "http://2013.igem.org/Team:TU-Eindhoven/Project"